Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure

NCT: NCT06859970 · ACTIVE_NOT_RECRUITING

NCT IDNCT06859970
StatusACTIVE_NOT_RECRUITING
Start Date2025-05-15
Completion2031-09

Brief Summary

The purpose of this early feasibility study is to evaluate the safety and feasibility of the device for percutaneous shunting of the interatrial septum and improvement of heart failure related symptoms. The primary goal is to determine if the device is safe to use. The findings from this study may be used to refine the intended patient population, the design of the device, or develop a subsequent randomized study.

Frequently Asked Questions

What is An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure?

An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure is a clinical trial registered under NCT06859970. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06859970?

The current status of NCT06859970 (An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure) is: ACTIVE_NOT_RECRUITING.

When did An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure start?

An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure started on 2025-05-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑